Clinical trials: Tobacco Smoking Cessation
Smoking
Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
The purpose of this study is to examine whether doxazosin will attenuate the ability of stress to precipitate smoking lapse behavior in treatment seeking daily smokers.
- Trial name
- NCT01730846
- Testing
- Doxazosin 4mg/day, Doxazosin 8mg/day
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Yale University
Smoking
Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment
The Objective of this study is to introduce a practically feasible multifaceted intervention in the preadmission clinic to help reduce smoking in preoperative surgical patients.
- Trial name
- NCT01243203
- Testing
- Champix
- Where
- Canada
- Volunteers
- 300 people
- Sponsor
- University Health Network, Toronto
Nicotine Dependence
Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
The purpose of this research study is to find out if an investigational drug, GSK598809 can help people who have very recently quit smoking; the investigators want to find out if continuing to take GSK598809 over six weeks can…
- Trial name
- NCT01188967
- Testing
- GSK598809
- Where
- United States
- Volunteers
- 84 people
- Sponsor
- Massachusetts General Hospital
Smoking Cessation
Quitxt Mobile Text Messaging Cessation Research Study
The health benefits of smoking cessation by age 30 are much greater than cessation later in life, including gaining 10 years of life, compared with those who continue to smoke.
- Trial name
- NCT05958667
- Testing
- Quitxt text messaging or Chat, Usual care
- Where
- United States
- Volunteers
- 1,200 people, healthy volunteers welcome
- Sponsor
- The University of Texas Health Science Center at San Antonio
Smoking Cessation
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
- Trial name
- NCT04798664
- Testing
- Removal of Financial Barriers, Financial Incentives, Mobile Health Application
- Where
- 5 sites in United States
- Volunteers
- 3,228 people
- Sponsor
- Abramson Cancer Center at Penn Medicine
Smoking Cessation
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo for smoking cessation.
- Trial name
- NCT00141167
- Testing
- varenicline
- Where
- 10 sites in South Korea, Taiwan
- Volunteers
- 250 people
- Sponsor
- Pfizer
COPD (Chronic Obstructive Pulmonary Disease)
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
The study hypothesis is that symptomatic current and former smokers with spirometric values within the normal range (post-bronchodilator FEV1/FVC≥0.70 and post-BD FVC ≥ 70% predicted will still derive symptomatic benefit from…
- Trial name
- RETHINC (NCT02867761)
- Testing
- Indacaterol/Glycopyrrolate
- Where
- 16 sites in United States
- Volunteers
- 780 people
- Sponsor
- University of Michigan
Cigarette Smoking, Nicotine Dependence
Reducing Tobacco Use Disparities Among Low-Income Adults
Most smokers, especially those who are poor, do not receive smoking cessation treatment during their healthcare visits. This study is evaluating a novel population health management intervention for low-income smokers.
- Trial name
- NCT03077737
- Testing
- Choose to Change, Enhanced usual care
- Where
- United States
- Volunteers
- 190 people, healthy volunteers welcome
- Sponsor
- Northwestern University
Smoking Cessation, Tobacco Use Disorder
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
This study will randomize 64 non-treatment seeking individuals who smoke cigarettes daily in a double-blind, placebo-controlled laboratory study testing the effects of cytisinicline on the neural substrates of cigarette cue…
- Trial name
- Cytisinicline (NCT06617312)
- Testing
- Cytisinicline
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- University of California, Los Angeles
Tobacco Use Cessation
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
This study aims to evaluate the effectiveness of an intervention to help people to quit smoking throughout an chat bot compared with usual assistance to increase long-term rates of nicotine abstinence in smoking outpatients with…
- Trial name
- Dej@lo (NCT03445507)
- Testing
- Chat bot, Usual care
- Where
- Spain
- Volunteers
- 542 people, healthy volunteers welcome
- Sponsor
- Gerencia de Atención Primaria, Madrid
Tobacco Use Disorder
Combining a Smoke Ending Aid With Behavioral Treatment - 1
The purpose of this study is to combine a smoke ending aid with behavioral treatment.
- Trial name
- NCT00006151
- Testing
- Behavioral Therapy
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Peter Gariti
Smoking Cessation
Cigarette Pack Inserts for Smoking Cessation
This study will test whether cigarette package inserts (i.e., small printed leaflets inside cigarette packs) with messages about the benefits of cessation and tips for quitting can help smokers quit.
- Trial name
- NCT04075682
- Testing
- Inserts with efficacy messages, Pictorial warnings on packs
- Where
- 2 sites in United States
- Volunteers
- 387 people, healthy volunteers welcome
- Sponsor
- University of South Carolina
Smoking Cessation; Tobacco Dependence
the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation
Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.
- Trial name
- NCT06762210
- Testing
- AI Molar Mind
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- Fayoum University
Smoking
Cue Reactivity in Virtual Reality: The Role of Context
The objectives of this proposal are to examine the role of context in a virtual reality (VR) environment and to explore the extent to which cues (i.e., contextual cues or explicit smoking cues) influence craving and physiological…
- Trial name
- NCT00862927
- Testing
- Breath Sample, Saliva Sample, Questionnaire
- Where
- United States
- Volunteers
- 21 people, healthy volunteers welcome
- Sponsor
- M.D. Anderson Cancer Center
Tobacco Use Disorder
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
This pilot clinical trial studies varenicline or nicotine patch in promoting smoking cessation among current smokers. Varenicline or nicotine patch may help people stop smoking
- Trial name
- NCT01771627
- Testing
- varenicline, nicotine patch
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- Roswell Park Cancer Institute
Quitting Smoking
Financial Incentives for Smoking Cessation Treatment Engagement
This study is being done to see if financial incentives increase the rate at which smokers engage in cessation treatment. A total of 540 participants will be enrolled by invitation from 6 primary care clinics of the participating…
- Trial name
- NCT04601870
- Testing
- No Financial Incentive, Financial Incentive (100 dollars), Financial Incentive (50 dollars)
- Where
- United States
- Volunteers
- 98 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Tobacco Cessation, Health Warning Label
Health Warnings and Counseling for Smoking Cessation
Tobacco use remains persistently high across South Asia, despite numerous public health efforts, and continues to significantly contribute to the burden of non-communicable diseases (NCDs) such as cardiovascular disease…
- Conditions
- Tobacco Cessation, Health Warning Label, Hypertension, Non Communicable Chronic Diseases
- Trial name
- NCT07098065
- Testing
- Graphical health warnings, Graphical health warnings plus pharmacist-led counselling, Routine pharmacy services (no intervention)
- Where
- Bangladesh
- Volunteers
- 3,400 people
- Sponsor
- Hitotsubashi University
Smoking Cessation
Pharmacist Intervention to Improve Smoking Cessation
The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit. The main questions it aims to answer are: Will smokers being screened for lung cancer with low-radiation-level chest…
- Trial name
- NCT06943287
- Testing
- Pharmacist Intervention
- Where
- United States
- Volunteers
- 80 people
- Sponsor
- University of Iowa
Smoking Cessation, Tobacco Dependence
tDCS as Add on Therapy for Treatment of Tobacco Dependence by Standardized Behaviour Therapy
As an add-on treatment to behavioural therapy for tobacco dependence, anodal transcranial direct current stimulation (tDCS) significantly increases the cessation rate compared to treatment with sham tDCS; endpoint analysis will…
- Trial name
- NCT01729507
- Testing
- tDCS, standardised behavioural therapy
- Where
- Germany
- Volunteers
- 40 people
- Sponsor
- Ludwig-Maximilians - University of Munich
Smoking Cessation
Factorial Design to Assess Quit-line Connections
Improved strategies and scalable interventions to engage low-socioeconomic status (SES) smokers in tobacco treatment are needed.
- Trial name
- NCT03760107
- Testing
- Connect Smokers to Treatment 1, Connect Smokers to Treatment 2, Connect Smokers to Treatment 3
- Where
- United States
- Volunteers
- 3,723 people
- Sponsor
- Minnesota Department of Health
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.